Is Xtacy Therapeutics Corp halal to invest in?

According to Musaffa's Shariah screening methodology, Xtacy Therapeutics Corp (XTCY.CN) is currently classified as NOT HALAL as of July 2025. The classification is based on an evaluation of the company's business activities and financial ratios to determine whether it meets Islamic investment guidelines.

Is Xtacy Therapeutics Corp a Shariah-compliant stock?

A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Xtacy Therapeutics Corp using these criteria to determine its compliance status.

Can Muslims buy shares of Xtacy Therapeutics Corp?

Muslim investors may consider investing in Xtacy Therapeutics Corp if it meets Shariah compliance standards. Investors typically review the company's business activities, debt levels, and non-permissible income before making a decision.

Why is Xtacy Therapeutics Corp classified as NOT HALAL?

Musaffa determines the Shariah status of Xtacy Therapeutics Corp by analyzing whether the company's core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.

How often is the Shariah compliance for Xtacy Therapeutics Corp updated?

The Shariah compliance status of Xtacy Therapeutics Corp may be updated periodically when new financial statements, earnings reports, or business activity information become available.

Can a halal stock like Xtacy Therapeutics Corp become non-compliant?

Yes. A stock that is currently Shariah-compliant may become non-compliant if the company's financial ratios exceed Shariah thresholds or its business activities change.

Where can I check the Shariah status of Xtacy Therapeutics Corp?

You can check the latest Shariah compliance status of Xtacy Therapeutics Corp on Musaffa's stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.

XTCY.CN Shariah Compliance

Screening Methodology: AAOIFI

NOT HALAL

Last Updated: July 17, 2025

Report Source: 2025 2nd Quarter Report

Xtacy Therapeutics Corp. Stock Analysis XTCY.CN

Canada N/A Nano Cap Report: Q2, 2025

Xtacy Therapeutics Corp. is an exploration company, which engages in the acquisition and exploration of oil and gas properties. The company is headquartered in Vancouver, British Columbia. The company went IPO on 2006-06-21. The firm's investment strategy is focused on the specific areas of pain, depression and mental illness. The focus of the Company is on global wellness, psychedelics, mycology, hemp and cannabidiol (CBD), healthcare-related target companies and their clinical studies and trials. By investing in techniques, such as micro-dosing using organic compounds and synthetic molecules, the Company is focusing on the research with the aim of providing wellness benefits with less side effects for people and the planet.

Key Statistics of Xtacy Therapeutics Corp (XTCY.CN)

Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.

Today's Range

CAD0.03CAD0.03

Today's Open

CAD0.03

Volume

41.00K

P/E Ratio (TTM)

52 Week Range

CAD0.02CAD0.40

Market Cap

1.74M

Avg. Volume

299.74K

Dividend Yield

Financial Metrics & Statements of Xtacy Therapeutics Corp (XTCY.CN)

FAQ's for Xtacy Therapeutics Corp (XTCY.CN)

According to Musaffa’s Shariah screening methodology, Xtacy Therapeutics Corp (XTCY.CN) is currently classified as NOT HALAL as of July 2025. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.